An Economical Diagnostic System for the Accurate and Rapid Detection and Prevention of Rare and Intractable Diseases,
Including Cancer and Neurodegenerative Disorders
- · Core technology for analyzing disease markers in blood introduced from GlycoMetrix (USA)
- · Established the world’s first rapid and accurate early cancer diagnosis system and database based on this proprietary technology
- · Early diagnostic systems developed for various cancers, including ovarian, breast, and pancreatic cancer
- · Ongoing R&D for early detection of major neurodegenerative diseases such as Parkinson’s and Alzheimer’s